FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of August __, 2019 between Beam Therapeutics Inc., a Delaware corporation (the “Company”), and ____________________ (“Indemnitee”).
BEAM THERAPEUTICS INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT NOVEMBER 8, 2018Investors’ Rights Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 8th day of November, 2018, by and among Beam Therapeutics Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
September 25, 2019 Courtney Wallace Dear Courtney,Employment Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This letter agreement (this “Agreement”) confirms the terms and conditions of your employment with Beam Therapeutics Inc. (the “Company”), effective as of the day prior to the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Effective Date”).
September 25, 2019 John Evans Dear John:Employment Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This letter agreement (this “Agreement”) confirms the terms and conditions of your employment as the President and Chief Executive Officer of Beam Therapeutics Inc. (the “Company”), working out of the Company’s headquarters located in Cambridge, Massachusetts, effective as of the day prior to the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of September 25, 2019 by and between Beam Therapeutics Inc. (the “Company”) and Giuseppe (“Pino”) Ciaramella (the “Executive”), and is effective as of the day prior to the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Effective Date”).
License AgreementLicense Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This License Agreement, made and entered into as of June 25, 2019 (“Agreement”), is by and between Beam Therapeutics Inc., a Delaware corporation having a place of business located at 26 Landsdowne Street, 2nd Floor, Cambridge, MA 02139 (“Licensee”) and MIL 21E, LLC a Delaware limited liability company having a place of business located at 21 Erie Street, Cambridge, MA 02139 (‘‘Licensor”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [**], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO BEAM THERAPEUTICS INC. IF PUBLICLY DISCLOSED. LICENSE AGREEMENT by and between BIO...License Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This License Agreement (this “Agreement”), effective as of March 27, 2019 (the “Effective Date”), is made by and between Bio Palette Co., Ltd., a Japanese corporation (“Bio Palette”), and Beam Therapeutics Inc., a Delaware corporation (“Beam”) (each, a “Party” and collectively, the “Parties”).
LEASE FOR 26 LANDSDOWNE STREET Cambridge, Massachusetts LANDLORD UP 26 LANDSDOWNE, LLC, a Delaware limited liability company TENANT BEAM THERAPEUTICS, INC.Lease Agreement • September 27th, 2019 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
